Guangzhou Development District Management Committee delegation visits Reforgene

On April 18, 2023, Liu Shi, Deputy Director of the Guangzhou Development District Management Committee, and Zhou Jingao, Party Secretary and Director of the Huangpu District Human Resources and Social Security Bureau, led a delegation to Guangzhou Reforgene Medicine Co., Ltd. for research and guidance. Dr. Liang Junbin, CEO of Reforgene, and others received and exchanged views with them.

Liu Shi and his delegation expressed heartfelt congratulations on Reforgene's first-place achievement in the "Third Entrepreneurship Star of Huangpu District". At the meeting, Liang Junbin introduced the company's development and growth, and expressed gratitude for the long-standing support of the Development District. The two sides held in-depth discussions on industry trends in novel biomedicines, intellectual property layout, the clinical trial progress of Reforgene's thalassemia innovative medicines, and policy support for high-quality enterprise development. Liu Shi placed earnest expectations on the broad application prospects and social value of gene editing technology. Zhou Jingao further introduced policies in areas such as enterprise-benefiting policies, talent recruitment and talent settlement, and expressed recognition of Reforgene's development speed and talent team building in recent years.

As a leading gene editing technology innovation enterprise in China, Reforgene will continue to uphold the philosophy of people-oriented innovation for life, and is committed to providing patients with safe and effective curative gene editing innovative medicines.